Trial Profile
PTH(1-34) and Pelvic Fracture Healing - a Randomized Controlled Trial
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 29 Jul 2022
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary)
- Indications Fracture
- Focus Therapeutic Use
- 05 Feb 2021 Planned primary completion date changed from 1 Dec 2020 to 1 Apr 2021.
- 21 Jan 2020 Status changed from recruiting to active, no longer recruiting.
- 08 Aug 2017 Status changed from not yet recruiting to recruiting.